How is ongoing medical therapy for nephrolithiasis monitored?

Updated: Jun 21, 2018
  • Author: Chirag N Dave, MD; Chief Editor: Bradley Fields Schwartz, DO, FACS  more...
  • Print
Answer

If a patient older than 40 years has formed a single stone that passed spontaneously or was easily treated, follow-up care for recurrent stones may be unnecessary. This patient is at a reasonably low risk for recurrence if adequate fluid intake is maintained. In other patients, whether or not they have elected directed metabolic therapy, routine follow-up care consists of plain abdominal radiography (or renal ultrasonography in the case of radiolucent stones) every 6-12 months.

If medical therapy is instituted, a 24-hour urinalysis 3 months after starting any new therapy should be performed to assess the degree of patient compliance and the adequacy of the metabolic response. Checking all possible metabolic parameters—not just the previously abnormal ones—is necessary because of the possibility of new problems arising as a result of the new therapy. Once a stable regimen has been established, annual 24-hour urinalyses are adequate.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!